How Old Are You? Why 65 Really Is the New 60 Insights for Retirement Go-Go Years Wes Chapman October 15, 2021 In pulling together the [...]
Read more
Category "Economic Policy"
Medigap Plans – 4 Things to Know
Medigap Plans – The 4 Things You Need to Know Medigap or Supplemental Plans – Completing Coverage at Home and Abroad August [...]
Read more
Introduction to Medicare – the Alphabet Soup
Introduction to Medicare - the Alphabet Soup, Part 1 “Medicare – I don’t know the first thing about it, but I [...]
Read more
Oncology Drug Price Transparency – Impact on Self-Insured Employers
Self-Funded Employer Health Plans Implications of Drug Price Transparency Strategies to Manage Medical Oncology Costs & Improve Care Quality Wes Chapman April 30, 2021 Introduction I [...]
Read more
Oncology Drug Discovery – 5 Years of Translational Success
Oncology Drug Discovery Delivering Translational Excellence & Fulfilling the Promise of Individualized Care March 31, 2021 Wes Chapman Figure 1 Translation: “the process of turning observations [...]
Read more
Nashville Property Tax Increase – A Review of Public Documents
Nashville Property Tax Increase A Review of Public Documents Wes Chapman & Pepper Hatch September 16, 2020 Summary and Conclusions On April 28th, 2020 Metro [...]
Read more
COVID-19; What is Angela Merkel telling us?
COVID-19; What is Angela Merkel telling us? “We have to understand that many people will be infected, … The consensus among [...]
Read more
An analysis of FDA oncology drug approvals – implications for patients and clinical trials
2018/2019 Oncology Drug FDA Approvals Notifications Implications for Early Phase Clinical Trials Dr. Wael Harb & Wes Chapman August 18, 2019 Illustration of an [...]
Read more
The Asymmetry of Lying in America
The Asymmetry of Lying in America Considerations of 18 U.S.C. Section 1001 December 31, 2018 Wes Chapman What do General Michael Flynn, Martha Stewart, [...]
Read more
EBITDA – The Oncology Valuation Series
EBITDA What is it, and why does it matter? The Oncology Valuation Series November 21, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. My [...]
Read more